本页面由Tiger Trade Technology Pte. Ltd.提供服务

大自然药业

4.13
-0.0200-0.48%
盘后:4.130.00000.00%16:22 EDT
成交量:1.85万
成交额:7.67万
市值:2,075.07万
市盈率:-1.20
高:4.30
开:4.09
低:4.07
收:4.15
52周最高:17.96
52周最低:2.00
股本:502.44万
流通股本:55.99万
量比:1.01
换手率:3.31%
股息:- -
股息率:- -
每股收益(TTM):-3.4482
每股收益(LYR):-8.0550
净资产收益率:-3.50%
总资产收益率:-1.72%
市净率:0.37
市盈率(LYR):-0.51

数据加载中...

2026/09/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/01/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/06

SEC问询函

Form CORRESP - Correspondence
2024/05/15

SEC问询函

Form CORRESP - Correspondence
2024/05/14

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/04/24

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/01/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/17

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/17

SEC问询函

CORRESP [Cover] - Correspondence